Processa Pharmaceuticals
Processa is a clinical-stage pharmaceutical company developing a BTK inhibitor and legacy assets including PCS499 and PCS12852.
10-QNov 13Latest SEC filing
Nov 5Latest story
November 2026
October 2026
August 2026
July 2026
Processa is a clinical-stage pharmaceutical company developing a BTK inhibitor and legacy assets including PCS499 and PCS12852.
November 2026
October 2026
August 2026
July 2026